APTIMMUNE BIOLOGICS, INC.

CHAMPAIGN, IL · Agritech · Still private

Autogenous PRRS vaccine produced in a novel porcine macrophage cell line

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · aptimmune.com

Sector: Agritech
Headquarters: CHAMPAIGN, IL
Latest Form D: $2.2M, Jul 2017
Total capital: $4M

Federal grants: $700K; 2 awards · 2015–2017; Rank in peer group#12 of 35
Private capital raised: $3.3M; 2 Form D · last Jul 2017; 112 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 0; 4 pending

Capital timeline

Latest events

Sep 2017Federal grantAgriculture · A New Class Of Porcine Reproductive And Respiratory Syndrome (prrs) Autogenous Vaccine Produced In A Novel Porcine Macrophage Cell Line$600K
Jul 2017Private capital raisedForm D · SEC · 2nd filing$2.2M
Jul 2015Private capital raisedForm D · SEC · 1st filing$1.1M
Jul 2015Federal grantAgriculture · A New Class Of Porcine Reproductive And Respiratory Syndrome (prrs) Autogenous Vaccine Produced In A Novel Porcine Macrophage Cell Line$100K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

<1months

from APTIMMUNE BIOLOGICS, INC.’s first federal award to its first private round.

First federal award · Jul 2015: Agriculture · $100K
First Form D · Jul 2015: $1.1M · 1st Form D
Awards before first raise: 1 award

An association in public records, not a cause or a prediction.

Standing among 35 peers

Line = median

Agritech · Molecule

Federal grants#12 · top 34%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

Aaron GilbertieExecutive Officer, DirectorNamed in SEC Form D filings
Federico ZuckermannExecutive Officer, DirectorNamed in SEC Form D filings
Gary DurackDirectorNamed in SEC Form D filings
Paul OlivoDirectorNamed in SEC Form D filings
Robert EasterDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 4

Dec 12, 2019PendingMethods Of Priming A Sus' Immune SystemUSPTOApplication 16312946
PendingNon-Simian Cells for Growth of African Swine Fever (ASF) VirusUSPTOApplication 62873075
PendingMethods Of Priming A Sus' Immune SystemUSPTOApplication PCTUS2017039110

Show all 4 patent records

Methods Of Priming A Sus' Immune SystemDec 12, 2019 · Application 16312946Pending
Non-Simian Cells for Growth of African Swine Fever (ASF) VirusApplication 62873075Pending
Methods Of Priming A Sus' Immune SystemApplication PCTUS2017039110Pending
Methods Of Priming A Sus' Immune SystemApplication 62354534Pending

N-Sense LLCSimilar federal contract value in Agritech · null in contracts
Better Meat Co.Similar federal contract value in Agritech · null in contracts
Enko Chem, Inc.Similar federal contract value in Agritech · null in contracts
FarmLink, Inc.Similar federal contract value in Agritech · null in contracts
WINNOWGEN, INCSimilar federal contract value in Agritech · null in contracts
FEN TECHNOLOGY LLCSimilar federal contract value in Agritech · null in contracts

Regulatory activity · Agritech

Sector-level, not company-level

09 Jul 2026Supplemental Disaster Assistance Programs, Marketing Assistance Loans, and Sugar ProvisionsCommodity Credit Corporation
09 Jul 2026Revisions to the Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Loan ProgramRural Business-Cooperative Service
06 Jul 2026Organic Certification Cost Share Program (OCCSP)Commodity Credit Corporation
29 Jun 2026Technical Guidelines for the Production of Regenerative Agricultural Biofuel FeedstocksEnergy and Environmental Policy Office
17 Jun 2026Rescinding Portions of U.S. Department of Agriculture Title VI Regulations To Conform More Closely With the Department of Justice's Regulations To Implement Executive Order 14281
11 Jun 2026Assistance for Specialty Crop Farmers (ASCF) Program; Approval of Information Collection RequestCommodity Credit Corporation

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.